This is a randomized pilot study to test the acceptance and use of PerHL among formerly incarcerated individuals
Eligible participants will be enrolled after providing informed consent .Participants will then complete a baseline assessment. After the interview, eligible participants will be randomly assigned to the intervention or control group. The research assistant (RA) will be blinded to the randomization allocation until after the consent process. For the purposes of this study, permuted block randomization with random block sizes of 2, 4 and 6 will be used. Intervention: Those randomized to the intervention arm will have access to PerHL. The intervention group will watch a demonstration by the RA and will practice using PerHL for 10-15 minutes, i.e. taking a picture of a document and uploading to PerHL, entering specific information, voice recording an appointment reminder. The RA will be responsible for providing technical support and assist with the need for initial support, e.g. phone-call or text-based support. At baseline, participants will be asked to provide a list of every organization they visited that may have health and health-related social information on them and receive consent to request their information to be sent to the participant and the study team on their behalf. Control: Participants randomized to the control arm will receive the standard of care patient portal (Epic®MyChart). The RA will give them an informational pamphlet outlining key features of the patient portal and guide them through the steps for signing up for a MyChart account, assist them to sign up, add the standard patient portal MyChart app to their phone, and provide them with the MyChart technical support hotline. Study Procedures: During the intervention phase, all participants will meet with the RA at baseline, 1- and 3 months. During the study, each participant will be asked to provide at least 5 verified locators who are likely to have knowledge of their whereabouts throughout follow-up. Each participant will be provided with $50 payment to participants for each completion of surveys at baseline, 1, 3 months. In addition, participants will be given $10 each month to travel to a location with free wireless so their information can be uploaded to the cloud and a list of available locations. In total, each participant will receive $180 for participation. For the 1- and 3-month follow-up period, the RA will ask participants to bring information collected and uploaded in PerHL and additional information that is important to the participant but was not uploaded.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Enrollment
100
Participants randomized to the PerHL arm will have access to PerHL + the standard of care patient portal (Epic®MyChart).
Participants randomized to the control arm will receive the standard of care patient portal (Epic®MyChart).
Yale School of Medicine
New Haven, Connecticut, United States
Acceptance - Intention to use
Assess intention to use the app developed for the project. Intention to use will be assessed by a survey conducted in person. This survey item is in development.
Time frame: 1 month post enrollment
Acceptance - Intention to use
Assess intention to use the app developed for the project. Intention to use will be assessed by a survey conducted in person. This survey item is in development.
Time frame: 3 month post enrollment
Use of Personal health information technology
Assess the number of times the personal health information app was accessed each week and the duration of time on the system per week. This will be assessed using tracking functionality built into the app.
Time frame: 1 month post enrollment
Use of Personal health information technology
Assess the number of times the personal health information app was accessed each week and the duration of time on the system per week. This will be assessed using tracking functionality built into the app.
Time frame: 3 month post enrollment
Perceived ease of use for the app
Assess how easy it was for the participant to use the app. Perceived ease of use will be assessed by self-report survey. This survey item is in development.
Time frame: 1 month post enrollment
Perceived ease of use for the app
Assess how easy it was for the participant to use the app. Perceived ease of use will be assessed by self-report survey. This survey item is in development.
Time frame: 3 month post enrollment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Perceived usefulness of the app
Assess how useful the participant found app to be. Perceived usefulness will be assessed by self-report survey. This survey item is in development.
Time frame: 1 month post enrollment
Perceived usefulness of the app
Assess how useful the participant found app to be. Perceived usefulness will be assessed by self-report survey. This survey item is in development.
Time frame: 3 month post enrollment
Attitude towards use of technology
Assess the participant's attitude towards using technology. Attitude towards technology will be assessed by self-report survey. This survey item is in development.
Time frame: 1 month post enrollment
Attitude towards use of technology
Assess the participant's attitude towards using technology. Attitude towards technology will be assessed by self-report survey. This survey item is in development.
Time frame: 3 month post enrollment
Completeness of data
Assess the proportion of health system data sources received by study team and/or patient (#organizational data received/ #organizational requests made), assess type of data received (# of medication list received/ requested or # of allergies received/requests made) to determine completeness of data.
Time frame: 1 month post enrollment
Completeness of data
Assess the proportion of health system data sources received by study team and/or patient (#organizational data received/ #organizational requests made), assess type of data received (# of medication list received/ requested or # of allergies received/requests made) to determine completeness of data.
Time frame: 3 month post enrollment
General self-efficacy
Assess participant self-efficacy. Self-efficacy will be assessed by self-report survey. This survey item is in development.
Time frame: 1 month post enrollment
General self-efficacy
Assess participant self-efficacy. Self-efficacy will be assessed by self-report survey. This survey item is in development.
Time frame: 3 month post enrollment
Medication adherence
Medication Adherence will be measured by personal health information technology use (MyChart) at Yale New Haven Hospital, medication adherence (as measured by ninety-day medication refill).
Time frame: 1 month post enrollment
Medication adherence
Medication Adherence will be measured by personal health information technology use (MyChart) at Yale New Haven Hospital, medication adherence (as measured by ninety-day medication refill).
Time frame: 3 month post enrollment
Engagement in primary care
Engagement in primary care will be measured by personal health information technology use (MyChart) at Yale New Haven Hospital, engagement in primary care (as measured by appointments made) via MyChart systems.
Time frame: 1 month post enrollment
Engagement in primary care
Engagement in primary care will be measured by personal health information technology use (MyChart) at Yale New Haven Hospital, engagement in primary care (as measured by appointments made) via MyChart systems.
Time frame: 3 month post enrollment